Seoul, South Korea

Sang Un Joo

This inventor holds 1 USPTO granted patent. Top assignee: Cha Biotech Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sang Un Joo. Retrieved from https://idiyas.com/inventor/sang-un-joo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Sang Un Joo in Postnatal Cell Research

Introduction

Sang Un Joo is an accomplished inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the area of postnatal adherent cells. His innovative work focuses on enhancing the yield and proliferation rate of these cells, which are crucial for various medical applications.

Latest Patents

Sang Un Joo holds a patent for "Postnatal adherent cells and preparation method therefor." This patent describes enhanced postnatal adherent cells and a preparation method that increases the yield and proliferation rate of adherent cells derived from placental tissues. The preparation method allows for the production of adherent cells that secrete proteins effective for neurological diseases and possess an improved ability to migrate to damaged tissues.

Career Highlights

Sang Un Joo is currently associated with Cha Biotech Co., Ltd., where he continues to advance his research and development efforts. His work has the potential to impact the treatment of neurological conditions significantly.

Collaborations

Some of his notable coworkers include Hye Sun Kim and Ah Reum Kang, who contribute to the collaborative efforts at Cha Biotech Co., Ltd.

Conclusion

Sang Un Joo's innovative research in postnatal adherent cells showcases his commitment to advancing biotechnology for medical applications. His contributions are paving the way for new treatments and therapies in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…